Stan Thijs

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Fox Rothschild LLP engages in the provision of legal services. Its practice areas include animal law, automotive, construction, business, corporate, drone law, employee benefits and compensation, entertainment and sports law, environmental, family law, fashion law, financial services industry, health law, insurance, international, immigration, media and defamation, nonprofit organizations, privacy and security, public companies, real estate, securities industry, taxation and wealth planning, technology, transportation and logistics, valuation law, and others. The company was founded by Edwin Fox and Jerome Rothschild in 1907 and is headquartered in Philadelphia, PA.

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Cage Pharmaceuticals, Inc. engages in the provision of health care services. The company is headquartered in Baltimore, MD.

Scheer Partners, Inc. provides real estate services. It offers commercial brokerage, investment sales, strategic consulting and construction and property management services. The company was founded by Robert Scheer in 1991 and is headquartered in Rockville, MD.

PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin.